Anúncio
Anúncio

MNOV

MNOV logo

Medicinova, Inc.

1.43
USD
Patrocinado
+0.03
+2.14%
08 de jan., 15:51 UTC -5
Encerrado
exchange

Pós-Mercado

1.43

0.00
-0.35%

Relatórios de Lucros MNOV

Rácio de surpresa positiva

MNOV separação 28 de 38 últimas estimativas.

74%

Próximo Relatório

Data do Próximo Relatório
17 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.11
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
+83.33%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
+83.33%

Medicinova, Inc. earnings per share and revenue

On 12 de nov. de 2025, MNOV reported earnings of -0.06 USD per share (EPS) for Q3 25, beating the estimate of -0.10 USD, resulting in a 41.18% surprise. Revenue reached 123.32 mil, compared to an expected --, with a --% difference. The market reacted with a -1.91% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of -0.11 USD, with revenue projected to reach -- USD, implying an aumentar of 83.33% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, Medicinova, Inc. reported EPS of -$0.06, beating estimates by 41.18%, and revenue of $123.32K, -- -- expectations.
The stock price moved down -1.91%, changed from $1.57 before the earnings release to $1.54 the day after.
The next earning report is scheduled for 17 de fev. de 2026.
Based on 4 analistas, Medicinova, Inc. is expected to report EPS of -$0.11 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio